Correlation of Ghrelin and Obestatin with Waist Circumference in Central Obese Men

Widya Kurniawati, Marsetio Donosepoetro, Andi Wijaya

Abstract


BACKGROUND: Central obesity is known as the cause of many metabolic disorders called Metabolic Syndrome. Accumulation of adipocytes in central obesity increases production of cytokines proinflammation. Free fatty acid increases in obesity that drives atherogenic dyslipidemia and insulin resistance. IDF 2005 states that waist circumference (WC) is regarded as the simple criteria of obesity. Energy imbalance lasting for a long period is a determinant factor for obesity, e.g. when energy intake is greater than energy expenditure. The brain and gastrointestinal tract work together to maintain this system. Ghrelin and Obestatin are two gut hormones that work in different ways to keep the energy balance. Ghrelin increases appetite but Obestatin decreases it. The two hormones play an important role in maintaining the dynamic equilibrium of energy balance. This study was aimed to determine correlation of Ghrelin and Obestatin with WC in central obese men.

METHODS: This was a cross sectional study involving 53 central obese men. Based on IDF 2005 central obesity is most easily measured by waist circumference using the guidelines ethnic group (not country of residence) specific. We used South Asia ethnic which including Chinese, Malay and Asian Indian population as criteria for this study, that was WC >90 cm, aged 20-60 years. Subjects who had smoking habit, any infectious disease, and ACS were excluded from the study. No restriction was applied on the kind of meals the subjects were having or activities they were doing. The correlation of waist circumference with ghrelin and obestatin was assessed with a significance level of 95% (α=0,05).

RESULTS: Patient's age was 40.9623±7.9080 year, waist circumferences was 102.1981±10.2696 cm, weight was 85.8679±16.5475 kg, height was 168.8066±6.3535 cm, BMI was 29.9723±2.4937 kg/m2. Concentration of Ghrelin were 0.70-13.72 ng/mL, and Obestatin 16.66-148.84 pg/mL. Pearson correlation showed that Ghrelin (r=-0.1114, p=0.4271) and Obestatin (r=-0.1781, p=0.2020) had no significant correlation with WC. But in patients WC ≥120 cm had significant negative correlation with Obestatin (r=-0.375, p=0.049).

CONCLUSIONS: There was no significant correlation of Ghrelin and Obestatin with WC in obese men. However, there was a negative correlation tendency found in patients with greater WC (≥102 cm).

KEYWORDS: obesity, ghrelin, obestatin, waist circumference (WC)


Full Text:

PDF

References


Wellen KE, Gokhan SH. Obesity induced inflammation changes in adipose tissue. J Clin Invest. 2003; 112: 1785-7, CrossRef.

Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005; 115: 1111-9, CrossRef.

Gil-Campos M, Canete R, Gil A. Hormones regulating lipid metabolism and plasma lipids in childhood obesity. Int J Obes Relat Metab Disord. 2004; 28: S75-80, CrossRef.

International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Berlin: IDF; 2005, article.

Kopelman PG. Obesity as a medical problem. Nature. 2000; 404: 635-43, PMID.

Allison DB, Saunders SE. Obesity in North America. Med Clin North Am. 2000; 84: 305-32, CrossRef.

Wood SC, Seeley RJ. Understanding the physiology of obesity: review of recent developments in obesity research. Int J Obese Relat Metab Disord. 2002; 26 (Suppl 4) :S8-10, CrossRef.

Tschop M, Nogueiras R. Biomedicine: Separation of conjoined hormones yields appetite rivals. Science. 2005; 310: 985-6, CrossRef.

Drucker DJ. The role of gut hormones in glucose homeostasis. J Clin.Invest. 2007; 117: 24-32, CrossRef.

Dufour RD. Gastrointestinal function and digestive disease. In: Kaplan LA, Pesce AJ, Kazmierczak SC. Textbook of Clinical Chemistry (Theory, Analysis, Corelation). 4th ed. USA: Mosbi Inc; 2003. p.549-66, NLMID.

Merchant JL. Tales from the crypts: regulatory peptides and cytokines in gastrointestinal homeostasis and disease. J Clin Invest. 2007; 117: 6-12, CrossRef.

Korner J, Leibel RL. To eat or not to eat - How the gut talks to the brain. New Eng J Med. 2003; 349: 926-8, CrossRef.

Gale S, Castracane VD, Mantzoros CS. Energy hemostasis, obesity, eating disorder: recent advances in endocrinology. J Nutr. 2003; 134: 295-8, PMID.

Shintani M, OgawaY, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, et al. Ghrelin, and endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonized leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes. 2001; 50: 227-32, CrossRef.

Hosoda H, Kojima M, Kangawa K. Ghrelin and the regulation of food intake and energy balance. Molecular Intervention. 2002; 2: 494-503, CrossRef.

Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest. 2007; 117: 13-23, CrossRef.

Zhang W, Zhao L, Lin TR, Chai B, Fan Y, Gantz I, et al. Inhibition of adipogenesis by ghrelin. Molecular Biology of the Cell. 2004; 15: 2484-91, CrossRef.

Kojima M, Hosada H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth hormone releasing acylated peptide from stomach. Nature. 1999; 402: 656-60, CrossRef.

Adrian TE. Importance of gut hormones in gastrointestinal, metabolic and malignant disease. Curr Opin Endocrin Diab. 2005; 12: 80-8, CrossRef.

Cummings DE, Overduin J, Schubert KEF. Roles for ghrelin in the regulation of appetite and body weight. Curr Opin Endocrinol Diab. 2005; 12: 72-9, CrossRef.

Zhang JV, Ren P, Kretchmer OA, Wei Luo, Rouch R, Klein C, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake. Science. 2005; 310: 996-9, CrossRef.

Rosická M, Krsek M, Matoulek M, Jarkovská Z, Marek J, Justová V, et al. Serum ghrelin levels in obese patients: the relationship to serum leptin levels and soluble leptin receptors levels. Physiol Res. 2003; 52: 61-6, PMID.

Zamrazilova H, Hainer V, Sedlackova D, Papezova H, Kunesova M, Bellisle F, et al. Plasma obestatin levels in normal weight, obese and anorectic women. Physiol Res. 2008; 57 (Suppl 1) : S49-55, PMID.

Zhang Z, Guo Z, Zheng X, Qin YW, Hu JQ, Chen SP. Circulating preprandial ghrelin to obestatin ratio is increasing in human obesity. J Clin Endocrin Metab. 2007; 92: 1875-80, CrossRef.

Otto B, Cuntz U, Fruehauf E. Weight gain decreases elevated plasma ghrelin concentration of patients with anorexia nervosa. Eur J. Endocrinol. 2001;145: 669-73, PMID.

Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodent. Nature, 2000; 407: 908-13, CrossRef.

Levin F, Edholm T, Schmidt PT, Gryback P, Jacobsson H, Degerblad M, et al. Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J. Clin Endocrinol Metab. 2006; 91: 3296-302, CrossRef.




DOI: https://doi.org/10.18585/inabj.v3i2.144

Copyright (c) 2011 The Prodia Education and Research Institute

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

 

Indexed by:

                  

               

                

 

 

The Prodia Education and Research Institute